| Medical and Health Sciences | Lifetime | 255 | US 137 | 99.99 |
| Biological Sciences | Lifetime | 152 | US 91 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 217 | US 80 | 99.96 |
| Biological Sciences | 2021-2025 | 342 | US 72 | 99.64 |
| Immunology | Lifetime | 7 | US 4 | 99.98 |
| Surgery | Lifetime | 42 | US 25 | 99.96 |
| Cancer Research | Lifetime | 39 | US 25 | 99.79 |
| Epidemiology | Lifetime | 423 | US 221 | 99.48 |
| Cardiology and Cardiovascular Medicine | Lifetime | 415 | US 233 | 99.45 |
| Immunology and Allergy | Lifetime | 112 | US 52 | 98.24 |
| Pulmonary and Respiratory Medicine | Lifetime | 975 | US 499 | 98.38 |
| Hematology | Lifetime | 468 | US 230 | 97.05 |
| Biochemistry | Lifetime | 949 | US 418 | 76.03 |
| Surgery | 2021-2025 | 20 | US 6 | 99.87 |
| Immunology | 2021-2025 | 8 | US 4 | 99.78 |
| Molecular Biology | 2021-2025 | 568 | US 158 | 96.96 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 361 | US 170 | 95.97 |
| Epidemiology | 2021-2025 | 611 | US 212 | 94.36 |
| Hematology | 2021-2025 | 199 | US 93 | 93.67 |
| Medical Genetics | 2021-2025 | 203 | US 95 | 90.80 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 459 | US 180 | 86.23 |
| Infectious Diseases | 2021-2025 | 641 | US 238 | 85.15 |
| Cancer Research | 2021-2025 | 336 | US 127 | 79.27 |
| Nutrition and Dietetics | 2021-2025 | 400 | US 85 | 80.65 |
| Biochemistry | 2021-2025 | 105 | US 29 | 76.58 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 1 | US 1 | 100.00 |
| Cell Adhesion Molecules Research | Lifetime | 3 | US 3 | 99.97 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 2 | US 1 | 99.99 |
| Protease and Inhibitor Mechanisms | Lifetime | 2 | US 2 | 99.95 |
| Lipoproteins and Cardiovascular Health | Lifetime | 3 | US 1 | 99.98 |
| Inflammasome and immune disorders | Lifetime | 3 | US 2 | 99.94 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 9 | US 6 | 99.76 |
| Coronary Interventions and Diagnostics | Lifetime | 27 | US 16 | 99.89 |
| Immune cells in cancer | Lifetime | 50 | US 20 | 99.60 |
| Cancer, Lipids, and Metabolism | Lifetime | 108 | US 58 | 99.45 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 201 | US 94 | 99.37 |
| Cardiac Imaging and Diagnostics | Lifetime | 346 | US 187 | 99.42 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 108 | US 39 | 98.97 |
| COVID-19 Clinical Research Studies | Lifetime | 358 | US 90 | 98.48 |
| Acute Myocardial Infarction Research | Lifetime | 261 | US 134 | 99.12 |
| Immune Response and Inflammation | Lifetime | 435 | US 211 | 98.89 |
| Biomarkers in Disease Mechanisms | Lifetime | 42 | US 7 | 97.73 |
| Cardiovascular Disease and Adiposity | Lifetime | 240 | US 124 | 98.66 |
| Chemokine receptors and signaling | Lifetime | 90 | US 39 | 98.40 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 238 | US 108 | 98.48 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 152 | US 79 | 98.70 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 265 | US 111 | 98.67 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 334 | US 154 | 98.80 |
| Cardiac Fibrosis and Remodeling | Lifetime | 107 | US 49 | 98.25 |
| IL-33, ST2, and ILC Pathways | Lifetime | 157 | US 70 | 98.43 |
| Galectins and Cancer Biology | Lifetime | 218 | US 86 | 97.46 |
| Aortic aneurysm repair treatments | Lifetime | 330 | US 183 | 98.02 |
| Acute Myeloid Leukemia Research | Lifetime | 603 | US 278 | 98.42 |
| Cholesterol and Lipid Metabolism | Lifetime | 237 | US 116 | 97.41 |
| Fatty Acid Research and Health | Lifetime | 381 | US 150 | 97.14 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 416 | US 219 | 97.43 |
| Long-Term Effects of COVID-19 | Lifetime | 673 | US 160 | 95.52 |
| Cardiac tumors and thrombi | Lifetime | 342 | US 171 | 96.90 |
| Transplantation: Methods and Outcomes | Lifetime | 537 | US 319 | 97.40 |
| Lipid metabolism and disorders | Lifetime | 366 | US 144 | 96.09 |
| Apelin-related biomedical research | Lifetime | 289 | US 99 | 92.65 |
| Infectious Aortic and Vascular Conditions | Lifetime | 387 | US 184 | 94.47 |
| Aortic Thrombus and Embolism | Lifetime | 182 | US 78 | 86.79 |
| Calpain Protease Function and Regulation | Lifetime | 807 | US 280 | 75.60 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 1 | US 1 | 99.89 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 1 | US 1 | 99.94 |
| Inflammasome and immune disorders | 2021-2025 | 4 | US 2 | 99.60 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 12 | US 4 | 99.71 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 43 | US 17 | 98.45 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 111 | US 41 | 98.44 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 88 | US 53 | 97.78 |
| Acute Myeloid Leukemia Research | 2021-2025 | 248 | US 141 | 97.80 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 206 | US 53 | 93.93 |
| Coronary Interventions and Diagnostics | 2021-2025 | 288 | US 70 | 96.69 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 80 | US 18 | 91.69 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 165 | US 64 | 91.14 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 951 | US 258 | 94.30 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 77 | US 10 | 90.48 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 207 | US 102 | 91.22 |
| Cell Adhesion Molecules Research | 2021-2025 | 218 | US 65 | 86.00 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 455 | US 86 | 90.57 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 106 | US 42 | 86.22 |
| Fatty Acid Research and Health | 2021-2025 | 214 | US 52 | 87.84 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 61 | US 3 | 82.65 |
| Lipid metabolism and disorders | 2021-2025 | 151 | US 41 | 85.93 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 692 | US 172 | 84.57 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 734 | US 169 | 66.32 |
| Hematological disorders and diagnostics | 2021-2025 | 597 | US 147 | 59.74 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 949 | US 231 | 51.35 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 1,000 | US 174 | 48.13 |